Page 165 - MEMORIA ANUAL 2021

MEMORIA ANUAL 2021 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GETCC
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
• Improved collection of hematopoietic stem cells and progenitors from Fanconi ane- mia patients for gene therapy purposes.
Mol Ther Methods Clin Dev. 2021 Jun 12;22:66-75. doi: 10.1016/j.omtm.2021.06.001. Sevilla J, Navarro S, Rio P, Sánchez-Domínguez R, Zubicaray J, Gálvez E, Merino E, Sebas- tián E, Azqueta C, Casado JA, Segovia JC, Alberquilla O, Bogliolo M, Román-Rodríguez FJ, Giménez Y, Larcher L, Salgado R, Pujol RM, Hladun R, Castillo A, Soulier J, Querol S, Fernández J, Schwartz J, García de Andoín N, López R, Catalá A, Surralles J, Díaz-de- Heredia C, Bueren JA .
• Wharton’s Jelly Mesenchymal Stromal Cells and Derived Extracellular Vesicles as Post-Myocardial Infarction Therapeutic Toolkit: An Experienced View. Pharmaceutics. 2021 Aug 26;13(9):1336. doi: 10.3390/pharmaceutics13091336. Muñoz-Domínguez N, Roura S, Prat-Vidal C, Vives J .
• Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).
Trials. 2021 Sep 6;22(1):595. doi: 10.1186/s13063-021-05430-2.
Soria-Juan B, García-Arranz M, Llanos Jiménez L, Aparicio C, González A, Mahillo Fernán- dez I, Riera Del Moral L, Grochowicz L, Andreu EJ, Marín P, Castellanos G, Moraleda JM, García-Hernández AM, Lozano FS, Sánchez-Guijo F, Villarón EM, Parra ML, Yáñez RM, de la Cuesta Diaz A, Tejedo JR, Bedoya FJ, Martín F, Miralles M, Del Rio Sola L, Fernández- Santos ME, Ligero JM, Morant F, Hernández-Blasco L, Andreu E, Hmadcha A, García- Olmo D, Soria B .
• A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol.
Trials. 2021 Oct 2;22(1):674. doi: 10.1186/s13063-021-05625-7.
García-García I, Guerra-García P, Ferreras C, Borobia AM, Carcas AJ, Queiruga-Parada J, Vicario JL, Mirones I, Solano C, Eguizabal C, Soria B, Pérez-Martínez A .
• CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies.
Mol Ther. 2021 Feb 3;29(2):636-44. doi: 10.1016/j.ymthe.2020.09.027.
Ortiz-Maldonado V, Rives S, Castellà M, Alonso-Saladrigues A, Benítez-Ribas D, Caballe- ro-Baños M, Baumann T, Cid J, García-Rey E, Llanos C, Torrebadell M, Villamor N, Giné E, Díaz-Beyá M, Guardia L, Montoro M, Català A, Faura A, González EA, Español-Rego M,
165